PDE5A and neoplasm: Besides, the PDE5 inhibition improved the anti-tumor efficacy of adoptive T cells therapy, reversed the tumor-induced immunosuppression, and enabled a favorable anti-tumor immune response that substantially delays tumor progression [136].